HOME >> BIOLOGY >> NEWS
Wetting Of Structured Or Imprinted Surfaces - Zooming Down Onto The Nanoscale

Wetting and dewetting phenenoma are all around us. The formation of rain droplets sitting on a plant leaf or hanging from a spiders web provide familiar examples for dewetting. On the other hand, the spreading of paint and adhesives on solid surfaces or the application of cosmetics onto the human skin rely on the wetting properties of these liquids. In fact, you could not read these lines without the tear films which wet your eyes and which are stabilized by the closure of your eyelids.

Now, imagine that we leave the macroscopic world and shrink the wetting structures to smaller and smaller length scales. Will we observe the same type of behavior as on the macroscopic scale? This question poses a general challenge to the science of colloids and interfaces. It is also of technological importance since our devices become smaller and smaller and their manufacture typically involves the processing of liquids.

Researchers at the Max Planck Institute of Colloids and Interfaces (Science, Vol. 282, 1 January 1999) have discovered new wetting phenomena at surfaces which are laterally structured on the micrometer scale. These surfaces contain hydrophilic and hydrophobic domains and, thus, have a position-dependent surface tension. This leads to 2-dimensional wettability patterns which act as templates for the 3-dimensional morphology of the liquid layers.

If the hydrophilic surface domains have the shape of long stripes, the liquid forms channels along those stripes. As one increases the volume of the liquid, these channels undergo a shape instability from a homogeneous channel state to another state with a single bulge. This instability is quite different from the classical Rayleigh-Plateau instability and represents a new type of wetting transition between two different morphologies of constant mean curvature. This latter transition can only occur because the contact angles of the channel do not satisfy the classical Young equation.

As far as applications ar
'"/>

Contact: Peter Lenz
lenz@mpikg-teltow.mpg.de
49-3328-46-588
Max-Planck-Gesellschaft
31-Dec-1998


Page: 1 2

Related biology news :

1. Imprinted gels hold promise for future medical devices
2. How Did Life Begin? Biochemical Evolution On Chemical Surfaces
3. Cellular Engineers Design Custom Cell Surfaces Able To Adhere To Synthetic Materials
4. Zooming liquid particles show technological promise
5. Nanoscale contact optimizes adhesion

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2017)... -- PMD Healthcare announces the release of its new ... (WMS), a remote, real-time lung health monitoring and management ... a Medical Device, Digital Health, and Chronic Care Management ... solutions that empower people to improve their healthcare and ... the first ever personal spirometer, Spiro PD, which was ...
(Date:3/7/2017)... , March 7, 2017 Brandwatch , the ... by The Prince,s Trust to uncover insights to support ... The Trust. The UK,s leading youth charity will be ... campaign results and get a better understanding of the topics and ... ...
(Date:3/2/2017)... -- Who risk to be deprived of its imprint ... https://www.reportbuyer.com/product/4313699/ WILL APPLE AND SAMSUNG CONFRONT ... sensors using capacitive technology represent a fast growing market, ... an increase of 360% of the number of fingerprint ... sensor market between 2014 and 2017 (source : N+1 ...
Breaking Biology News(10 mins):
(Date:3/20/2017)... , ... March 20, 2017 , ... ... HEPARIN calibration verification / linearity test kit has received US FDA 510(k) clearance ... VALIDATE® HEPARIN kit evaluates Heparin Anti-Xa activity in a human plasma matrix. ...
(Date:3/20/2017)... NEW YORK , March 20, 2017  Attorney Advertising ... behalf of purchasers of the BioAmber Inc. ("BioAmber" or the "Company") ... obtain additional information and assist the investigation by visiting the ... concerns whether BioAmber and certain of its officers and/or directors ... Act of 1934. ...
(Date:3/19/2017)...  Array BioPharma Inc. (Nasdaq: ARRY ) ... Food and Drug Administration,s (FDA) Division of Oncology Products ... for the treatment of NRAS -mutant melanoma, a ... This action was based on thorough discussions and communications ... approval, and followed the late cycle review meeting held ...
(Date:3/18/2017)... , March 17, 2017  A new study ... who historically have been considered ineligible for curative ... reirradiation using intensity-modulated proton therapy (IMPT) for lung ... patients were free from local recurrence at one ... ten patients experienced severe side effects. The study ...
Breaking Biology Technology:
Cached News: